Class: Genitourinary System
Dosage Form: Tablets
Description: For relief of urogenital spasms
Flavoxate hydrochloride………….200 mg
Flavoxate hydrochloride is a synthetic compound. It exerts an antispasmodic action of the smooth muscles of the urogenital system. Genurin is indicated for the relief of spastic conditions of the urogenital tract, especially for the more resistant and readily recurrent forms.
Genurin is indicated:
- For symptomatic relief of dysuria, urgency, nocturia, supra-pubic pain, frequency and incontinence in affections of the bladder and prostate such as cystitis, cystalgia, prostatitis, urethritis, urethrocystitis and urethrotrigonititis
- As an adjuvant in the antispasmodic treatment of the calculi of the kidney and ureter, urinary spastic disorders caused by catheterization, cystoscopy and the sequelae of surgery on the lower urinary tract
- For the relief of spastic states in the female genital tract such as pelvic algias, dysmenorrhea, uterine hypertonia and dyskinesia
Known hypersensitivity to the drug.
Patients who have the following obstructive conditions: pyloric or duodenal obstruction, achalasia, obstructive intestinal lesions of ileus, gastrointestinal hemorrhage and obstructive uropathies of the lower urinary tract.
Adverse effects have rarely been reported and include: nausea and vomiting (which usually do not occur when the drug is taken on a full stomach), dryness of mouth, vertigo, headache and drowsiness (which usually disappears when doses are reduced or given at wide intervals). Emotional instability, visual and accommodation distrubances, increased ocular tension, urticaria and other dermatoses. Mental confusion especially in the elderly patient, dysuria, tachycardia, fever, eosinophilia and constipation at high doses.
Dosage and Administration:
One tablet 3-4 times daily, at regular intervals.
Pregnancy and Lactation:
Animal studies have shown that the drug has no adverse effects on pregnancy and the fetus. However, as with any other drug caution in its use is recommended in case of pregnancy, especially during the first three months of pregnancy.
The following cautions apply:
- In patients with concomitant infections of the urogenital tract, flavoxate hydrochloride should be administered in combination with appropriate anti-infective therapy
- The drug should be given cautiously to patients with glaucoma, especially in closed-angle forms
- Patients who operate a motor vehicle or machinery or participate in activities where alertness is required should be warned of the possible side effects, which are drowsiness, blurred vision, and vertigo
- It is not recommended for use in infants and children under 12 years of age since the therapeutic value and safety of this drug have not yet been determined in patients in this age group
Box of 3 strips of 10 tablets each.
Store at room temperature.